Skip to content

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 28, 2026 results vs estimates

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd · E.600332.SHG · China
Use symbol E.600332.SHG in our API & Excel add-in to retrieve this data ↓
20.25
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend -25%
Bubble Risk LOW
Realised Volatility (20D) 19.18%

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Forecast

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is negative (3 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 19.2% a year, a typical one-standard-deviation range is 19.70–20.80 over a week, 19.13–21.37 over a month and 16.37–24.13 over a year. (Signals as of 5 Nov 2026.)

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Price Chart

MacroFinance.ai

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
P/E
15.21x
Stretched vs own history
QoQ +14.7%
YoY +7.9%
now 15.209410.91 low15.21 high
ⓘP/E As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
P/S
0.42x
Cheap vs own history
QoQ −3.4%
YoY −22.4%
now 0.42140.4 low0.55 high
ⓘP/S As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
P/B
0.84x
Cheap vs own history
QoQ −2.9%
YoY −24.1%
now 0.84340.8 low1.12 high
ⓘP/B As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
EV/EBITDA
8.92x
Mid-range vs own history
QoQ +21.6%
YoY −15.6%
now 8.92436.35 low10.63 high
ⓘEV/EBITDA As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
EV/Sales
0.34x
Cheap vs own history
QoQ +3.8%
YoY −40.2%
now 0.34350.3 low0.58 high
ⓘEV/Sales As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Earnings Yield
6.6%
Weak vs own history
QoQ −12.8%
YoY −7.3%
now 6.57496.57 low9.16 high
ⓘEarnings Yield As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Dividend Yield
8.5%
Strong vs own history
QoQ —
YoY —
now 8.49018.49 low8.95 high
ⓘDividend Yield As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Market Cap
$32.9B
Lowest in 5 years
QoQ −3.2%
YoY −21.8%
now 32922.266731,248 low42,319 high
ⓘMarket Cap As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Net Debt
-$6.1B
Mid-range vs own history
QoQ −25.8%
YoY −347.3%
now -6087.6313-8,204 low2,462 high
ⓘNet Debt As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Net Debt / EBITDA
-2.02x
Mid-range vs own history
QoQ −13.2%
YoY −446.4%
now -2.0245-2.33 low0.58 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Current Ratio
1.64x
Mid-range vs own history
QoQ −0.6%
YoY +2.5%
now 1.64141.57 low1.65 high
ⓘCurrent Ratio As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Quick Ratio
1.32x
Mid-range vs own history
QoQ −1.7%
YoY +0.8%
now 1.31811.24 low1.34 high
ⓘQuick Ratio As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Interest Coverage
6.68x
Weak vs own history
QoQ −8.6%
YoY −25.4%
now 6.6786.68 low8.95 high
ⓘInterest Coverage As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Debt / Equity
0.15x
Low vs own history
QoQ +14.6%
YoY −72.8%
now 0.1490.12 low0.55 high
ⓘDebt / Equity As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Piotroski F-Score
4
Mid-range vs own history
QoQ 0.0%
YoY 0.0%
now 44 low5 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Altman Z-Score
2.16
Weak vs own history
QoQ −1.0%
YoY −9.6%
now 2.16062.12 low2.39 high
ⓘAltman Z-Score As of 22 Nov 2026.See Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  14 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  14 members-only factors: Beneish M-Score, Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd fundamentals: income statement, balance sheet & cash flow

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd reported revenue of 77.45bn CNY and net income of 2.98bn CNY in FY2025, the year ended 31 December 2025 — revenue up 3.3% and net income up 5.2% on the prior year. Free cash flow was -979.7m CNY. These figures are as reported in the filings, not restated: 29 fiscal years and 99 quarters of history, back to December 1997.

Revenue (FY2025)
77.45bn CNY
+3.3%
Net income
2.98bn CNY
+5.2%
Gross margin
15.18%
Free cash flow
-979.7m CNY
-142.3%
Net debt
5.75bn CNY
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd income statement, annual, as reported · CNY billions unless stated
CNY billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue77.4574.9975.5270.7969.01
Cost of revenue65.6962.5261.3757.5555.82
Gross profit11.7612.4714.1413.2413.19
Research & development0.610.760.780.820.87
Selling, general & admin.8.058.118.247.357.53
Operating income3.103.605.125.074.79
EBITDA4.064.075.465.004.39
Interest expense0.430.440.470.450.44
Pre-tax income3.693.615.115.044.72
Income tax0.630.610.850.790.75
Net income2.982.844.063.973.72

Download Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.600332.SHG&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 29 fiscal years and 99 quarters, the filing vintages behind each number and API access.
Create free account

Figures in CNY, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (China)

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is a listed security in China. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is a listed security in China. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd price?
The latest close is 20.25 (5 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd in an uptrend?
As of 5 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is negative (3 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
20-day realised volatility is 19.2% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 5.5% over a month and 2.7% over a week.
What factors affect Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
28 backtested tactical asset allocation strategies trade Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd historical data?
In the Free historical data section of this page: the last 10 years of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.600332.SHG&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2019.22
2026-11-1919.41
2026-11-1819.46
2026-11-1719.68
2026-11-1619.59
2026-11-1319.35
2026-11-1219.47
2026-11-1119.51
2026-11-1019.72
2026-11-0919.91
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, production, and sale of health products; and wholesale, retail, and import export of Western medicines, traditional Chinese medicines, and medical devices. The company also offers bio-innovation, consumer health, and medical services; Xiaochaihu granules; Qingkailing and Baoji, Xia Sangju product series; Angong Niuhuang, Zishen Yutai, Xiaoke, Huatuo Zaizao, Zhuangyao Jianshen, and Shujin Jianyao pills; compound Danshen and Naoxinqing tablet series; Banlangen, Compound Banlangen, and Dashen Kouyanqing granules series; and honey-processed Chuanbei and Shedan Chuanbei loquat syrup. In addition, it provides antibacterial and anti-inflammatory drugs, andrological drugs, and analgesics and antipyretics; Wanglaoji herbal tea, Ciningji series, Lixiaoji series, and Yerou coconut milk; and advertising services. Further, the company engages in the medical research industry; technology services industry; leasing and business services; and scientific research and technical services industry. It operates through hospitals, community healthcare facilities, and retail outlets through distributors and agents. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.